Experts have promised a game-changing set of new vaccines for a variety of diseases, including cancer.
READ ALSO: Shocking as Woman finds deadly 6-foot snake in her bed while changing bed sheets
A major pharmaceutical company believes that vaccinations for cancer, cardiovascular and autoimmune illnesses, and other conditions would be available by 2030.
Studies into these vaccinations are also showing “tremendous promise,” with some researchers claiming that 15 years of advancement has been “unspooled” in 12 to 18 months as a result of the Covid jab’s success.
Moderna’s chief medical officer, Dr Paul Burton, believes the company will be ready to deliver such therapies for “all sorts of disease areas” in as little as five years.
READ ALSO: BREAKING] Organ harvesting: Obasanjo writes UK court, appeals for Ekweremadu
The company, which developed a breakthrough coronavirus vaccine, is now working on cancer vaccines that target several tumor types.
“We will have that vaccine, and it will be highly effective, and it will save hundreds of thousands, if not millions, of lives,” Burton said. I believe we will be able to provide individuals all around the world with personalized cancer vaccinations against a variety of tumor forms.”
He also stated that various respiratory illnesses might be covered by a single injection, protecting vulnerable persons from Covid, flu, and respiratory syncytial virus (RSV), and that mRNA therapeutics could be offered for rare diseases that now have no medications. mRNA-based therapies operate by instructing cells on how to produce a protein that activates the body’s immunological response to sickness.
“I think we’ll have mRNA-based therapies for rare diseases that were previously untreatable, and I think we’ll be approaching a world where you can truly identify the genetic cause of a disease and, with relative ease, go and edit that out and repair it using mRNA-based technology,” Burton said.
